Searched for
N GOVINDARAJAN
Aurobindo Pharma names K Nithyananda Reddy as managing director"Mr. Reddy has been a key member of Aurobindo leadership and has played a pivotal role in the Company’s growth journey since inception. A v...- Aurobindo Pharma's COVID-19 vaccine plan in limbo after partner fails to get EUA in TaiwanAurobindo Pharma on Tuesday said that its COVID-19 vaccine UB-612 programme hasn't progressed, as its partner Vaxxinity failed to secure th...
- Aurobindo Pharma Managing Director N Govindarajan resigns"His resignation was considered and accepted by the board of directors in its meeting today. N Govindarajan will be relieved from the servi...
- Aurobindo Pharma expects to commercialise vaccine facility by Apr-MayThe Hyderabad-based drug major is investing around Rs 275 crore on the facility which would be utilised to produce vaccines for the treatme...
- Developing a range of products for US, EU markets: Aurobindo PharmaThe firm is developing eight inhalers and six nasal sprays, out of which two products have already been filed, Aurobindo Pharma Managing Di...
- Aurobindo Pharma plans to launch 50-60 products in US in FY21The company has received final approval for six ANDAs (abbreviated new drug application) and launched four products in the fourth quarter o...
- Aurobindo Pharma acquires dermatology business from Sandoz in a $900 million cash dealThe acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities ...
- Aurobindo Pharma Q1 profit slips 12% to Rs 455 croreRevenue from operations stood at Rs 4,250.27 crore for the quarter under consideration.
- Aurobindo Pharma tumbles 7% on muted Q4For 2017-18, the company posted a net profit of Rs 2,423.2 crore, up 5.3 per cent, from Rs 2,301.7 crore in 2016-17.
- Aurobindo Pharma Q1 net profit down 11% at Rs 518 crThe company had posted a net profit of Rs 584.90 crore during the same period of previous fiscal, Aurobindo Pharma said in a BSE filing.
- Rakesh Jhunjhunwala grills Aurobindo top brass post Q4, stock up 10%Jhunjhunwala, who owns 1.08% stake in the drug maker quizzed the management about the sales.
- When Rakesh Jhunjhunwala grilled Aurobindo top brass; brokerages see 58% upside in stockTaking into consideration the long-term outlook of the company, Jhunjhunwala asked questions about new initiatives being taken by the compa...
- When Rakesh Jhunjhunwala took stock of his investment in Aurobindo PharmaIn terms of opportunity, we do not see more than three-four players getting into that. So that is the level of opportunity which exists.
- Aurobindo Pharma Q1 net profit up 24% at Rs 585 croreConsolidated total income from operations also rose to Rs 3,725.90 crore for the quarter under consideration as against Rs 3,298.93 crore f...
- Aurobindo Pharma Q1 net up 4% at Rs 432 croreAurobindo Pharma today reported a 4.1 per cent increase in its net profit at Rs 432.4 crore during the first quarter ended June 30, 2015.
- Aurobindo Pharma may spend Rs 1,300 crore toward capex in FY15-16Growing export revenue offers hedge against repayment of Foreign Currency Term Loans, which is payable over 4 to 5 years, he added.
- Aurobindo Pharma's July-September quarter net rises 58.3% to Rs 372 croreThe total operating income grew 50.5 per cent to Rs 2,881.2 crore during the quarter under review as against Rs 1,913.9 crore during the sa...
- Aurobindo Pharma Q2 Net up 5.7% at Rs 235 croreAurobindo Pharma today said its consolidated net profit rose 5.7 per cent to Rs 235 crore for the second quarter ended September 30, 2013.
- Aurobindo Pharma posts net profit of Rs 92 cr in Q3Aurobindo Pharma today posted consolidated net profit of Rs 91.81 crore for the third quarter ended December 31, 2012.
- Aurobindo Pharma eyes 25% revenue from custom research businessAurobindo Pharma is eyeing to garner at least 25% of its annual revenues from the custom research and manufacturing (Crams) business in the...
Load More
